SM

Sureshchandra Manilal Patel

Active Director Director DIN 10771714
DIN 10771714 First appointment Sep 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sureshchandra Manilal Patel

Data last updated:

Sureshchandra Manilal Patel is a Director at Riveca Pharmaceuticals Private Limited (since 2024). The company operates in Pharma.

DIN 10771714
Primary Designation Director
Industry Pharma
First Appointment 07 Sep 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Sep 20242024Active

Board colleagues of Sureshchandra Manilal Patel

Directorship timeline

Open interactive timeline →
Riveca Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sureshchandra Manilal Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sureshchandra Manilal Patel

Sureshchandra Manilal Patel currently holds 1 directorship: Riveca Pharmaceuticals Private Limited (Director, since 07 Sep 2024).

Sureshchandra Manilal Patel was first appointed on 07 Sep 2024 as Director at Riveca Pharmaceuticals Private Limited.

The current boards of Sureshchandra Manilal Patel's companies include Siddharth Anirudhbhai Narela (Riveca Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available